Predicting hearing loss in facioscapulohumeral muscular dystrophy.
نویسندگان
چکیده
Facioscapulohumeral muscular dystrophy (FSHD) has an estimated prevalence of 4–7 per 100,000 population, making it the third most common type of muscular dystrophy. The classic form of FSHD is characterized by weakness that is slowly progressive and often asymmetric in the face, scapulae, upper arms, lower legs, and abdomen. The age at onset of symptoms varies from infancy to middle age, and life expectancy is normal or almost normal. Aside from muscle weakness, other manifestations include chronic pain, hearing loss, retinal telangiectasias and exudation (Coats syndrome) that can progress to retinal detachment and vision loss, cardiac arrhythmias, cognitive impairment, and epilepsy. There seems to be an increased prevalence of hearing loss in FSHD compared with the general population. Hearing loss has been described particularly in patients with infantile-onset FSHD but also in typical cases. In severe infantile-onset cases, the hearing loss can be profound, and if not detected may lead to delayed language development and even the false perception of cognitive impairment. Consensus-based recommendations suggest routine hearing testing in infants and preschool-age children diagnosed with FSHD. FSHD manifests in 2 clinically identical types; both types are related to inappropriate expression of DUX4 protein in muscle cells, which leads to the development of FSHD by a toxic gain of function mechanism. DUX4 expression has a different cause in each type. FSHD type 1 (FSHD1), which is inherited in an autosomal dominant fashion, accounts for about 95% of cases. In FSHD1, inappropriate DUX4 expression is caused by contraction of a region on chromosome 4q35 known as D4Z4. In the general population, D4Z4 consists of 11–100 repeated DNA segments. In FSHD1, one D4Z4 allele is contracted (1–10 repeats, EcoRI fragment less than 38 kb, EoRI/Bln1 fragments less than 35 kb) and the other D4Z4 allele has the normal number of repeat units. The contraction results in a more open chromatin structure and if it occurs on a permissive chromosomal background (4qA haplotype), DUX4 transcription is activated. In the less common FSHD type 2 (FSHD2), seen in fewer than 5% of patients, the D4Z4 region is not contracted. Instead, in about 80% of FSHD2 cases, the abnormal DUX4 expression is caused by mutations in the SMCHD1 gene that affect the D4Z4 chromatin structure. The inheritance of FSHD2 is related to the interaction between the independent inheritance of an SMCHD1 mutation on chromosome 18 and a permissive 4qA haplotype. In this issue of Neurology®, Lutz et al. describe the hearing loss in FSHD and its relationship to genotype. In a cohort of 59 individuals with FSHD, 11 had substantial hearing loss diagnosed from birth to 7 years. In 2 patients, hearing loss was identified by newborn hearing screen, and 3 patients had progression of hearing loss. In 53 participants, information regarding the contracted EcoRI/BlnI fragment, which reflects the number of residual repeats, was available, and a negative association was detected between hearing loss and fragment size. There was no hearing loss in patients with EcoRI/BlnI fragment size of more than 20 kb (i.e., 4–10 repeats). In the cohort with EcoRI/BlnI fragment less than 20 kb reflecting a larger repeat contraction (i.e., 1–3 residual repeats), about one-third (10/31) of patients had hearing loss. It seems that FSHD-associated hearing loss may worsen over time, as reported before, while some individuals can have stable hearing loss over long periods of time. Why hearing loss is stable in some patients while progressive in others is not clear. The authors’ data provide support for the current testing recommendations, which can be outlined as follows:
منابع مشابه
The auditory, vestibular, and oculomotor system in facioscapulohumeral dystrophy.
Auditory, vestibular and oculomotor function tests were performed in 14 FSHD patients (7 men, 7 women, aged 19-74 years) with autosomal dominant facioscapulohumeral dystrophy (FSHD) due to chromosome 4q35 associated DNA rearrangements. (Cochlear) sensorineural hearing loss (SNHL) in excess of that expected for their age was found in 6 patients: in 3 at the higher frequencies and in 3 also at th...
متن کاملHigh Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice.
Facioscapulohumeral muscular dystrophy (FSHD) is caused by mutations leading to ectopic expression of the transcription factor DUX4, and encompasses both muscle-related and non-muscle phenotypes. Mouse models bearing this gene represent valuable tools to investigate which pathologies are due to DUX4 expression, and how DUX4 leads to these pathologies. The iDUX4(2.7) mouse contains an X-linked d...
متن کاملExpression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.
Facioscapulohumeral muscular dystrophy (FSHD) is a common form of muscular dystrophy characterized by an asymmetric progressive weakness and wasting of the facial, shoulder and upper arm muscles, frequently accompanied by hearing loss and retinal vasculopathy. FSHD is an autosomal dominant disease linked to chromosome 4q35, but the causative gene remains controversial. DUX4 is a leading candida...
متن کاملCeliac Disease Associated with Facioscapulohumeral Muscular Dystrophy
Introduction. The association of celiac disease and facioscapulohumeral muscular dystrophy was not reported earlier in the literature. Case presentation. A 35-year-old woman diagnosed clinically with facioscapulohumeral muscular dystrophy 23 years ago. In the family history patients’ mother was diagnosed with facioscapulohumeral muscular dystrophy, too. Physical examination revealed bilateral f...
متن کاملبررسی اثر مدل های ساده و پیچیده یادگیری حرکتی روی عملکرد اندام فوقانی بیماران دچار Facioscapulohumeral muscular dystrophy حین فعالیت های روزمره
مقدمه: عمده مشکل بیماران دیستروفی انجام فعالیتهای روزمره می باشد که به دلیل ضعف عضلات اندام فوقانی موجب وابستگی آنها می گردد. هدف توانبخشی این بیماران افزایش کارایی اندام فوقانی در جهت ایجاد استقلال در زندگی شخصی است. در این مطالعه اثر یادگیری حرکتی روی کارایی اندام فوقانی بررسی شد. روش کار: دو مطالعه مختلف برای بررسی اثر یادگیری حرکتی و پیچیدگی مدل یادگیری روی عملکرد اندام فوقانی طراحی و دو مد...
متن کاملUK Facioscapulohumeral Muscular Dystrophy (FSHD) Patient Registry
The United Kingdom (UK) Facioscapulohumeral Dystrophy (FSHD) Patient Registry launched in May 2013. Funded by the Muscular Dystrophy Campaign and supported by the TREAT-NMD Alliance. This patient driven registry collects the internationally agreed core dataset, an outcome of an ENMC Workshop held in 2010 [1], through a novel online portal (http://www.fshd-registry. org/uk). Genetic details are ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Neurology
دوره 81 16 شماره
صفحات -
تاریخ انتشار 2013